An Open-Label, Multicenter, Multinational Extension Study Of The Long-Term Safety And Pharmacokinetics Of Repeated Biweekly Infusions Of NeoGAA In Patients With Pompe Disease
Phase of Trial: Phase II/III
Latest Information Update: 04 Jul 2019
Price : $35 *
At a glance
- Drugs GZ 402666 (Primary)
- Indications Glycogen storage disease type II
- Focus Adverse reactions
- Acronyms NEO-EXT
- Sponsors Sanofi; Sanofi Genzyme
- 07 Feb 2019 According to a Sanofi media release, results from this study were presented at the 15th Annual WORLDSymposium.
- 07 Feb 2019 According to a Sanofi media release, from NEO1 study, 19 patients are entered in this extansion study.
- 07 Feb 2019 Results presented in a Sanofi media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History